Sign in

CIK 0001604464 · Non-accelerated filer<br>Smaller reporting company

Atara Biotherapeutics, Inc.

Sign in to watch
Ticker
ATRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
460920988
Phone
805-623-4211
Business address
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
  1. 8-K Event Material agreement
  2. 8-K Event Bylaws or fiscal year change
  3. 4 Open-market sale President and CEO sold 14,806 shares at $5.04 ($74,548)
  4. 4 Open-market sale EVP, Head of R&D sold 4,124 shares at $5.03 ($20,760)
  5. 4 Open-market sale SVP, GC & Secretary sold 3,430 shares at an average $5.03 ($17,269)
  6. 4 Open-market sale Chief Financial Officer sold 5,940 shares at $5.04 ($29,908)
  7. 10-Q Report Quarterly Report
  8. 8-K Event Material agreement · Results of operations · Exit or restructuring costs · Executive or director change
  9. S-8 Other Securities Offered to Employees in Benefit Plans
  10. 4 Open-market sale President and CEO sold 14,220 shares at $7.20 ($102,384)
  11. 4 Grant or award Director acquired 20,500 shares (grant or award)
  12. 4 Grant or award Director acquired 20,500 shares (grant or award)
  13. 4 Grant or award Director acquired 20,500 shares (grant or award)
  14. 4 Grant or award Director acquired 20,500 shares (grant or award)
  15. 4 Grant or award Director acquired 20,500 shares (grant or award)
  16. 4 Grant or award Director acquired 20,500 shares (grant or award)
  17. 4 Grant or award Director acquired 20,500 shares (grant or award)
  18. 4 Grant or award Director acquired 20,500 shares (grant or award)
  19. 4 Grant or award Director acquired 20,500 shares (grant or award)
  20. 8-K Event Shareholder vote results

Page 17 of 57 · 1,133 filings